Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: The Ontario Grade 8 HPV Vaccine Cohort Study

CMAJ

Volumn 187, Issue 2, 2015, Pages E74-E81

  Smith, Leah M ^a   Kaufman, Jay S ^a   Strumpf, Erin C ^a   Lévesque, Linda E ^b  

^a MCGILL UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; WART VIRUS VACCINE;

ADOLESCENT; ADOLESCENT SEXUAL BEHAVIOR; ARTICLE; ATTRIBUTABLE RISK; CANADA; COHORT ANALYSIS; CONDOM; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; POPULATION BASED CASE CONTROL STUDY; PREGNANCY; QUASI EXPERIMENTAL STUDY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SEXUAL BEHAVIOR; SEXUAL EDUCATION; SEXUALLY TRANSMITTED DISEASE; THERAPY EFFECT; VACCINATION; ADOLESCENT BEHAVIOR; ADOLESCENT PREGNANCY; INCIDENCE; PAPILLOMAVIRUS INFECTIONS; PATIENT ATTITUDE; PSYCHOLOGY; SEXUALLY TRANSMITTED DISEASES; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADOLESCENT BEHAVIOR; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; ONTARIO; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; PREGNANCY IN ADOLESCENCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; VACCINATION;

EID: 84922221277     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.140900     Document Type: Article

References (36)

1. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006;24 Suppl 1:S1-15.
2. Parry J. Vaccinating against cervical cancer. Bull World Health Organ 2007;85:89-90.
3. Muñoz N, Bosch FX, Castellsague X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004;111:278-85.
4. Lacey CJ, Lowndes CM, Shah KV. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006;24 Suppl 3:S3/35-41.
5. Haas M, Ashton T, Blum K, et al. Drugs, sex, money and power: an HPV vaccine case study. Health Policy 2009; 92:288-95.
6. Markowitz LE, Tsu V, Deeks SL, et al. Human papillomavirus vaccine introduction - the first five years. Vaccine 2012;30 Suppl 5:F139-48.
7. Haug CJ. Human papillomavirus vaccination-reasons for caution. N Engl J Med 2008;359:861-2.
8. Lippman A, Melnychuk R, Shimmin C, et al. Human papillomavirus, vaccines and women's health: questions and cautions. CMAJ 2007;177:484-7.
9. Forster A, Wardle J, Stephenson J, et al. Passport to promiscuity or lifesaver: press coverage of HPV vaccination and risky sexual behavior. J Health Commun 2010;15:205-17.
10. Kirby D. The impact of schools and school programs upon adolescent sexual behavior. J Sex Res 2002;39:27-33.
11. Mueller TE, Gavin LE, Kulkarni A. The association between sex education and youth's engagement in sexual intercourse, age at first intercourse, and birth control use at first sex. J Adolesc Health 2008;42:89-96.
12. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 2007; 45:107-14.
13. Colucci R, Hryniuk W, Savage C. HPV vaccination programs in Canada: Are we hitting the mark? Report card on cancer in Canada. Toronto: Cancer Advocacy Coalition of Canada; 2008. p. 7-10.
14. Ontario's HPV vaccination program. Toronto: Ministry of Health and Long-Term Care; 2013. Available: www.health .gov.on.ca/en/ms/hpv/ (accessed 2014 Mar. 13)
15. ICES data dictionary. Toronto: Institute of Clinical Evaluative Sciences; 2014. Available: https://datadictionary.ices.on.ca /Applications /DataDictionary/Default.aspx (accessed 2014 Mar. 6).
16. Appendix 4: Data sources and population health indicators limitations. An appendix to the initial report on public health (2009). Toronto: Ministry of Health and Long-Term Care, Public Health Division; 2009. Available: www.health.gov.on.ca/en /public/publications/pubhealth/init-report/pdfs/appendix4.pdf (accessed 2014 Mar. 6)
17. Smith LM, Lévesque LE, Nasr M, et al. Validity of the Immunization Record Information System (IRIS) database for epidemiologic studies of the human papillomavirus (HPV) vaccine. Can J Clin Pharmacoepidemiol 2010;17:e90-127.
18. Cook TD. "Waiting for life to arrive": a history of the regression-discontinuity design in psychology, statistics and economics. J Econom 2007;142:636-54.
19. Imbens GW, Lemieux T. Regression discontinuity designs: a guide to practice. J Econom 2008;142:615-35.
20. Lee H, Munk T. Using regression discontinuity design for program evaluation. In: Proceedings of the 2008 Joint Statistical Meeting; 2008 Aug. 3-7
21. Denver. Alexandria (VA): American Statistical Association; 2008. p. 1675-82. Available: www .amstat .org/sections/srms/proceedings/y2008/Files/301149.pdf (accessed 2014 Oct. 21).
22. Bor J, Moscoe E, Mutevedzi P, et al. Regression discontinuity designs in epidemiology: causal inference without randomized trials. Epidemiology 2014;25:729-37.
23. O'Keeffe AG, Geneletti S, Baio G, et al. Regression discontinuity designs: an approach to the evaluation of treatment efficacy in primary care using observational data. BMJ 2014; 349:g5293.
24. Bednarczyk RA, Davis R, Ault K, et al. Sexual activity-related outcomes after human papillomavirus vaccination of 11-to 12-year-olds. Pediatrics 2012;130:798-805.
25. Mullins TL, Zimet GD, Rosenthal SL, et al. Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination. Arch Pediatr Adolesc Med 2012;166:82-8.
26. Mather T, McCaffery K, Juraskova I. Does HPV vaccination affect women's attitudes to cervical cancer screening and safe sexual behaviour? Vaccine 2012;30:3196-201.
27. Liddon NC, Leichliter JS, Markowitz LE. Human papillomavirus vaccine and sexual behavior among adolescent and young women. Am J Prev Med 2012;42:44-52.
28. Forster AS, Marlow LA, Stephenson J, et al. Human papillomavirus vaccination and sexual behaviour: cross-sectional and longitudinal surveys conducted in England. Vaccine 2012; 30:4939-44.
29. Fenton KA, Johnson AM, McManus S, et al. Measuring sexual behavior: methodological challenges in survey research. Sex Transm Infect 2001;77:84-92.
30. Clark LR, Brasseux C, Richmond D, et al. Are adolescents accurate in self-report of frequencies of sexually transmitted diseases and pregnancies? J Adolesc Health 1997;21:91-6.
31. Chen RT, Davis RL. RHodes PH. Special methodological issues in pharmacoepidemiology studies of vaccine safety. In: Strom BL, editor. Pharmacoepidemiology. 4th ed. Chichester (UK): John Wiley & Sons; 2005. p. 455-85.
32. Nelson JC, Jackson ML, Weiss NS, et al. New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol 2009;62:687-94.
33. Rosenthal SL, Rupp R, Zimet GD, et al. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health 2008;43:239-45.
34. Kessels SJ, Marshall HS, Watson M, et al. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine 2012;30:3546-56.
35. Leval A, Herweijer E, Ploner A, et al. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study. J Natl Cancer Inst 2013;105:469-74.
36. Ali H, Donovan B, Wand H, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ 2013; 346:f2032.